Antibody Subclass and Glycosylation Shift Following Effective TB Treatment

With an estimated 25% of the global population infected with Mycobacterium tuberculosis (Mtb), tuberculosis (TB) remains a leading cause of death by infectious diseases. Humoral immunity following TB treatment is largely uncharacterized, and antibody profiling could provide insights into disease res...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Grace, Patricia S., Dolatshahi, Sepideh, Lu, Lenette L., Cain, Adam, Palmieri, Fabrizio, Petrone, Linda, Fortune, Sarah M., Ottenhoff, Tom H. M., Lauffenburger, Douglas A., Goletti, Delia, Joosten, Simone A., Alter, Galit
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8287567/
https://ncbi.nlm.nih.gov/pubmed/34290702
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.679973
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados